10.1016/j.psychres.2020.113626 Psychiatry Res
PlexusDx access pathway PlexusDx offers clinician-supervised GLP-1 protocols inside its Weight Management Protocols collection including Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared
Key results (52 weeks): Max walking distance 13% (median gain: +26 m) Pain-free walking distance 11% (median gain: +14 m) QoL (VascuQoL-6) improved significantly Lower rates of rescue treatment and (HR 0.46) Effects persisted 5 weeks after treatment stopped Better anklebrachial index, HbA1c, and weight loss (5.2 kg) Safety: Well tolerated Serious adverse events similar to placebo (19% vs 20%) Discontinuation due to AEs: 7% (semaglutide) vs 4% (placebo) No treatment-related deaths How does it compare
Your plan is tailored not only to your weight goals, but to your tissue composition, metabolism, and aesthetic timeline
Healthy fats from sources like avocados, olive oil, nuts, and fatty fish (salmon, mackerel) are crucial because tirzepatide can cause temporary gallbladder changes